Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/24/2023 | $8.50 → $14.00 | Underperform → Hold | Jefferies |
| 2/17/2023 | $14.00 → $17.00 | Sector Perform → Outperform | RBC Capital Mkts |
| 10/20/2022 | $18.00 | Hold → Buy | The Benchmark Company |
| 2/10/2022 | $19.00 → $13.50 | Hold → Underperform | Jefferies |
| 10/22/2021 | $28.00 → $22.00 | Neutral | Credit Suisse |
| 10/21/2021 | $29.00 → $20.00 | Sector Perform | RBC Capital |
| 10/20/2021 | Outperform → Mkt Perform | William Blair | |
| 7/22/2021 | $30.00 → $29.00 | Sector Perform | RBC Capital |
Healthcare Services Group, Inc. (NASDAQ:HCSG) today announced the appointment of Vikas Singh as EVP & Chief Financial Officer, effective September 3, 2024. He will oversee HCSG's accounting and finance operations, and play a key role in corporate development, investor relations, and the success of its long-term growth strategy. Mr. Singh brings over two decades of diverse experience in finance, strategy and operations to the Company. Most recently, he served as Managing Director of Leveraged Finance & Capital Markets at Bank of America Securities. Prior to that he worked in the Financial Sponsors Group at Credit Suisse and in the Asia-Pacific Credit Card Group at Citibank. Mr. Singh began
SC 13G/A - HEALTHCARE SERVICES GROUP INC (0000731012) (Subject)
SC 13G/A - HEALTHCARE SERVICES GROUP INC (0000731012) (Subject)
SC 13G/A - HEALTHCARE SERVICES GROUP INC (0000731012) (Subject)
Delivers QoQ and YoY Growth In Revenue, Earnings and Cash Flow Revenue of $428.1 million, in line with expectations. Net income and diluted EPS of $14.0 million and $0.19. Reported and adjusted cash flow from operations of $4.3 million and $19.0 million. Reaffirms Q4 revenue estimate of $430.0 to $440.0 million and FY 2024 cash flow forecast of $40.0 to $55.0 million. Healthcare Services Group, Inc. (NASDAQ:HCSG) today reported results for the three months ended September 30, 2024. Ted Wahl, Chief Executive Officer, stated, "We're very pleased with our third quarter results, which underscore the positive momentum we're carrying into the fourth quarter. Executing on our three stra
Healthcare Services Group, Inc. (NASDAQ:HCSG) today announced the appointment of Vikas Singh as EVP & Chief Financial Officer, effective September 3, 2024. He will oversee HCSG's accounting and finance operations, and play a key role in corporate development, investor relations, and the success of its long-term growth strategy. Mr. Singh brings over two decades of diverse experience in finance, strategy and operations to the Company. Most recently, he served as Managing Director of Leveraged Finance & Capital Markets at Bank of America Securities. Prior to that he worked in the Financial Sponsors Group at Credit Suisse and in the Asia-Pacific Credit Card Group at Citibank. Mr. Singh began
Raises Second Half 2024 Revenue Estimates, Reaffirms Full-Year 2024 Cash Flow Forecast Revenue of $426.3 million, in line with expectations. Net income and diluted EPS of ($1.8) million and ($0.02); includes $0.22 impact of client restructuring charges. Reported and adjusted cash flow from operations of $16.3 million and ($2.4) million. Raises Q3 and Q4 revenue estimates to $425.0 to $435.0 million and $430.0 to $440.0 million. Reaffirms 2024 adjusted cash flow range of $40.0 to $55.0 million. Healthcare Services Group, Inc. (NASDAQ:HCSG) today reported results for the three months ended June 30, 2024. Ted Wahl, Chief Executive Officer, stated, "Our field-based team deli
Baird analyst Andrew Wittmann maintains Healthcare Services Group (NASDAQ:HCSG) with a Neutral and raises the price target from $13 to $14.
4 - HEALTHCARE SERVICES GROUP INC (0000731012) (Issuer)
4 - HEALTHCARE SERVICES GROUP INC (0000731012) (Issuer)
4 - HEALTHCARE SERVICES GROUP INC (0000731012) (Issuer)
Jefferies upgraded Healthcare Services Group from Underperform to Hold and set a new price target of $14.00 from $8.50 previously
RBC Capital Mkts upgraded Healthcare Services Group from Sector Perform to Outperform and set a new price target of $17.00 from $14.00 previously
The Benchmark Company upgraded Healthcare Services Group from Hold to Buy and set a new price target of $18.00
10-Q - HEALTHCARE SERVICES GROUP INC (0000731012) (Filer)
8-K - HEALTHCARE SERVICES GROUP INC (0000731012) (Filer)
8-K - HEALTHCARE SERVICES GROUP INC (0000731012) (Filer)
Delivers QoQ and YoY Growth In Revenue, Earnings and Cash Flow Revenue of $428.1 million, in line with expectations. Net income and diluted EPS of $14.0 million and $0.19. Reported and adjusted cash flow from operations of $4.3 million and $19.0 million. Reaffirms Q4 revenue estimate of $430.0 to $440.0 million and FY 2024 cash flow forecast of $40.0 to $55.0 million. Healthcare Services Group, Inc. (NASDAQ:HCSG) today reported results for the three months ended September 30, 2024. Ted Wahl, Chief Executive Officer, stated, "We're very pleased with our third quarter results, which underscore the positive momentum we're carrying into the fourth quarter. Executing on our three stra
Raises Second Half 2024 Revenue Estimates, Reaffirms Full-Year 2024 Cash Flow Forecast Revenue of $426.3 million, in line with expectations. Net income and diluted EPS of ($1.8) million and ($0.02); includes $0.22 impact of client restructuring charges. Reported and adjusted cash flow from operations of $16.3 million and ($2.4) million. Raises Q3 and Q4 revenue estimates to $425.0 to $435.0 million and $430.0 to $440.0 million. Reaffirms 2024 adjusted cash flow range of $40.0 to $55.0 million. Healthcare Services Group, Inc. (NASDAQ:HCSG) today reported results for the three months ended June 30, 2024. Ted Wahl, Chief Executive Officer, stated, "Our field-based team deli
Healthcare Services Group, Inc. (NASDAQ:HCSG) today issued the following statement in response to LaVie Care Centers' announcement that it had filed for Chapter 11 bankruptcy protection in the Northern District of Georgia. As a result of LaVie's filing, the Company estimates a Q2 non-cash charge of approximately $0.20 per share. The Company expects to continue providing services to LaVie and expects no impact on future revenue or earnings. Additionally, the Company anticipates no disruption in postpetition payments and reiterates its previously shared Q2 and 2024 adjusted cash flow expectations of $5.0 million to $15.0 million and $40.0 million to $55.0 million, respectively. Ted Wahl, Ch